UPDATE ON SCHIZOPHRENIA – A pooled analysis of six randomized trials of olanzapine and comparator atypical antipsychotic agents (n=1990) reports that five distinct patterns of response can be identified in patients with schizophrenia starting treatment (Stauffer et al. Schizophr Res 2011; epublished April 12, 2011). Response patterns were measured with the Positive and Negative Syndrome Scale (PANSS).
Latest News
Delay in hospitalization with clozapine
May 25, 2011UPDATE ON SCHIZOPHRENIA – A U.K. study reports that time to hospitalization was significantly delayed in patients with schizophrenia or schizoaffective disorder discharged on clozapine rather than on another antipsychotic medication (Nyakyoma & Morriss. Psychopharmacol Bull 2010; 43: 67-81).
MS incidence higher in African Americans
April 15, 2011REPORT FROM THE 63rd ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY (AAN), HONOLULU, HAWAII, APRIL 9-16, 2011 – MS is generally described as a disease that primarily affects Caucasians, however, a new study from southern California suggests that the incidence is higher in African Americans than in other racial/ethnic groups (Langer-Gould et al. AAN 2011; abstract P06.032).
Comorbidities common, delay MS diagnosis
April 15, 2011REPORT FROM THE 63rd ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY (AAN), HONOLULU, HAWAII, APRIL 9-16, 2011 – The U.S. National Health and Wellness Survey, an annual internet survey of health behaviours, reports that people with MS more commonly report comorbidities compared to those in the general population (Meletiche et al. AAN 2011; abstract P06.045).